CDKN2A and neoplasm: In a tumor–T cell coculture system, an aging phenotype emerges in healthy donor‐derived human T cells followed with stimulation of tumor‐derived cAMP, including decreased expression of CD28, shortened telomere, increased p53, p21, and p16 [87].